Patient and Lesion Characteristics of Evaluable Tumors
| Subject no. | Tumor type | No. in SoC | No. with PET uptake | No. RECIST-evaluable | FAS | SUVpeak at 40 min |
| 1 | Breast | 1 | 1 | 1 | 1 | 4.6 |
| 2 | Breast | 4 | 3 | 1 | 1 | 5.9 |
| 3 | Breast | 14 | 5 | 1 | 0 | — |
| 4 | Breast | 1 | 1 | 1 | 1 | 3.44 |
| 5 | Breast | 2 | 2 | 0 | 0 | — |
| 6 | Breast | 3 | 1 | 1 | 1 | 3.0 |
| 7 | Breast | 5 | 5 | 2 | 2 | 2.8, 10.1 |
| 8 | Breast | 3 | 1 | 1 | 1 | 3.6 |
| 9 | Breast | 5 | 2 | 2 | 2 | 4.8, 5.7 |
| 10 | Breast | 7 | 7 | 1 | 1 | 3.7 |
| 11 | Breast | 2 | 1 | 0 | 0 | — |
| 12 | Breast | 7 | 7 | 0 | 0 | — |
| 13 | Breast | 2 | 2 | 1 | 1 | 2.2 |
| 14 | Colorectal carcinoma | 6 | 1 | 0 | 0 | — |
| 15 | Colorectal carcinoma | 5 | 0 | 0 | 0 | — |
| 16 | Colorectal carcinoma | 3 | 3 | 2 | 2 | 2.8, 2.9 |
| 17 | Colorectal carcinoma | 6 | 4 | 2 | 2 | 2.3, 3.3 |
| 18 | Colorectal carcinoma | 4 | 2 | 2 | 2 | 1.4, 1.7 |
| 19 | Colorectal carcinoma | 1 | 1 | 1 | 0 | — |
| 20 | Colorectal carcinoma | 2 | 1 | 0 | 0 | — |
| 21 | Colorectal carcinoma | 4 | 4 | 0 | 0 | — |
| 22 | Melanoma | 7 | 4 | 2 | 2 | 6.6, 6.3 |
| 23 | Melanoma | 5 | 2 | 1 | 1 | 8.1 |
| 24 | Ovarian | 12 | 8 | 1 | 1 | 3.6 |
| 25 | Ovarian | 3 | 1 | 1 | 1 | 4.3 |
| 26 | Cervical | 5 | 1 | 0 | 0 | — |
| 27 | Non–small cell lung cancer | 8 | 2 | 2 | 2 | 3.5, 3.8 |
| 28 | Malignant pheochromocytoma | 13 | 8 | 5 | 5 | 5.3, 8.0, 10.1, 5.8, 4.4 |
| 29 | Neuroendocrine | — | 3 | 0 | 0 | — |
| 30 | Neuroendocrine (gastrinoma) | 9 | 2 | 2 | 1 | 2.5 |
| 31 | Glioblastoma (grade IV) | 1 | 1 | 1 | 1 | 3.2 |
| 32 | Head and neck | 6 | 5 | 0 | 0 | — |
| 33 | Head and neck | 3 | 1 | 1 | 1 | 9.7 |
| 34 | Head and neck | 11 | 5 | 3 | 3 | 4.2, 3.8, 2.7 |
| 35 | Pancreatic | 6 | 1 | 1 | 1 | 3.7 |
| 36 | Pancreatic | 7 | 1 | 1 | 1 | 4.9 |
| 37 | Mesothelioma | 3 | 1 | 1 | 1 | 5.3 |
| 38 | Osteogenic sarcoma | 1 | 1 | 0 | 0 | — |
| 39 | Cancer of unknown primary | 1 | 1 | 1 | 1 | 2.8 |
| Total | 188 | 102 | 42 | 39 |
SoC = standard-of-care images; FAS = final analysis set.